Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Line of Laboratory Balances Focuses on Most Often Used Weighing Tasks

By BiotechDaily International staff writers
Posted on 08 May 2014
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Image: Some examples of the new Entris line of laboratory balances (Photo courtesy of Sartorius).
Biotech and other life science researchers can increase their productivity by selecting one or more new laboratory balances from an innovative new line.

Sartorius (Gottingen, Germany) recently introduced the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions.

The line of Entris balances comprised 15 analytical and precision balances that cover a weighing capacity from 60 grams to 8.2 kilograms with a readability of 0.1 milligram to 0.1 gram.

The logical key assignment on the Entris and its clearly structured user interface make daily routine weighing much easier. Most models of the new Entris family are equipped with a monolithic weighing system featuring external adjustment or an internal, motorized adjustment function. This guarantees consistently accurate weighing results, which are displayed on the easy-to-read backlit, high-contrast display.

The Entris system, which can display information in German, English, French, Italian, Spanish, Russian and Polish, is equipped with applications for density determination, animal weighing, counting, conversion, and weighing in percent. The easily removable draft shield and stainless steel parts render the Entris quick and easy to clean.

Related Links:
Sartorius

comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.